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Commentary to ‘‘Endovascular Repair of Infrarenal Abdominal
Aortic Aneurysms in High Surgical Risk Patients.’’
P. De Rango* and F. Verzini
Division of Vascular and Endovascular Surgery, University of Perugia,
Ospedale S. Maria della Misericordia, Perugia, ItalyIn this article, theAuthors claimthat their results support
elective early endovascular repair (EVAR) of asymptom-
atic abdominal aortic aneurysm (AAA) in high-surgical
risk patients. Although it is important to challenge cur-
rent practice, these statements are rather provocative
and not fully supported by data in the study.1
Indeed, recent level 1 evidence has dampened enthu-
siasm for EVAR in unfit patients: EVAR2 trial failed to
demonstrate any benefit of endovascular repair over ob-
servation in high-risk patients showing a high perioper-
ative mortality rate (9%) and no difference in 4 years
overall survival rate (as low as 36%) in the two groups.2
On the contrary, in thepresent study theAuthors showed
a low perioperative mortality of 4.3% and an exception-
ally high long-term survival of up to 85% at 3 years.
What is the matter of debate?
Large disparity in outcomes of EVAR for high risk
patients is the inevitable consequence of the impossi-
bility to reach a standardized consensus to define
high-risk criteria.1e4 Different grading of comorbid-
ities and disparate evaluations of multiple risk factors
in the same patient continue to be suggested and
applied to stratify the patient risks. Therefore there
is the chance to puzzle within the same category
both patients with unacceptable high risk and patients
with fair-moderate risk.
For example, in the present study 38 patients were
considered at risk for pulmonary disease according
to rather soft criteria. Indeed the patient who failed
EVAR and was immediately converted to open repair
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his good surgical fitness. Oppositely, 4 perioperative
deaths occurred in patients with prohibitive surgical
risks: over-octogenarians with an ASA IV score, all
with previous cardiac antecedents and chronic ob-
structive pulmonary disease. For this latter group it
might have been safer to recognize the limits of which-
ever treatment over the natural history of the patient.
The long-term survival reported, as high as 85% at 3
years, should be consideredwith caution, since this rate
is similar or even better than that of a population at low
cardiovascular risk. These results are even more aston-
ishing considering that about half of the population
was represented by ultra-octogenarians. It is evident
that in addition to EVAR treatment, a small number of
observations as well as careful patient selection had
a great influence on the study outcomes.Unfortunately,
we do not have information on the number and health
status of the patients refused for surgery in the same
study period to better understand the inclusion criteria
used by the Authors. Furthermore, there is more than
a chance that only very few of the 92 high risk operated
patients reached follow-up at 3 years (the numbers of
patients at risk for each survival interval were not dis-
played) to generalize good survival outcome.
Lessons from this and other studies on high risk
patients suggest that without homogeneity in the def-
inition, any generalization of EVAR outcomes and
indications should not be accepted. The excessively
high enthusiasm for the satisfactory results shown in
the present article should be cautiously trimmed
down and a more realistic picture of outcomes and
survival in severe risk patients should be considered.
The very good results of early EVAR reported here
confirm that aortic endografting remains a safe optionrved.
153Commentary to Endovascular Repair of AAA High Surgical Risk Patientsonly in the presence of optimal anatomical suitability
and after careful evaluation of individual patient char-
acteristics in a thorough pre-operative risk-benefit
assessment that cannot be generalized.
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